NIOX Group (LON:NIOX) Announces Earnings Results

NIOX Group (LON:NIOX) released its quarterly earnings data on Wednesday. The company reported GBX 1.41 EPS for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.14% and a net margin of 14.37%.

NIOX Group Stock Performance

Shares of NIOX Group stock traded up GBX 1 during trading hours on Wednesday, hitting GBX 69. 784,239 shares of the company were exchanged, compared to its average volume of 803,888. The stock has a market capitalization of £290.40 million, a price-to-earnings ratio of 42.07 and a beta of 0.92. The company has a current ratio of 3.81, a quick ratio of 1.94 and a debt-to-equity ratio of 1.36. NIOX Group has a 1 year low of GBX 53.84 and a 1 year high of GBX 76. The business has a 50-day moving average of GBX 65.54 and a 200-day moving average of GBX 61.58.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.